Eloctate and Lorcaserin Extended-Release Tablets
Determining the interaction of Eloctate and Lorcaserin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Eloctate with Fc Fusion Protein (recombinant)
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Eloctate-Lorcaserin Hydrochloride
- Eloctate-Lorcaserin Tablets
- Eloctate-Lorcet
- Eloctate-Lorcet Plus
- Eloctate-Lorcet Tablets
- Eloctate-Lorlatinib
- Lorcaserin Extended-Release Tablets-Eloctate with Fc Fusion Protein recombinant
- Lorcaserin Extended-Release Tablets-Elotuzumab
- Lorcaserin Extended-Release Tablets-Elotuzumab Intravenous
- Lorcaserin Extended-Release Tablets-Eloxatin
- Lorcaserin Extended-Release Tablets-Elppa CoQ10 coenzyme Q-10
- Lorcaserin Extended-Release Tablets-Elspar